Lazard Asset Management’s Ironwood Pharmaceuticals IRWD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-14,542
| Closed | -$126K | – | 2338 |
|
|
2024
Q1 | $126K | Sell |
14,542
-860
| -6% | -$7.45K | ﹤0.01% | 1459 |
|
|
2023
Q4 | $176K | Buy |
15,402
+11
| +0.1% | +$126 | ﹤0.01% | 1436 |
|
|
2023
Q3 | $148K | Buy |
15,391
+8,779
| +133% | +$84.4K | ﹤0.01% | 1487 |
|
|
2023
Q2 | $70K | Buy |
6,612
+6,503
| +5,966% | +$68.8K | ﹤0.01% | 1717 |
|
|
2023
Q1 | $1K | Sell |
109
-10,779
| -99% | -$98.9K | ﹤0.01% | 2241 |
|
|
2022
Q4 | $134K | Buy |
+10,888
| New | +$134K | ﹤0.01% | 1413 |
|
|
2022
Q3 | – | Sell |
-10,900
| Closed | -$125K | – | 2451 |
|
|
2022
Q2 | $125K | Buy |
10,900
+4,630
| +74% | +$53.1K | ﹤0.01% | 1434 |
|
|
2022
Q1 | $78K | Buy |
+6,270
| New | +$78K | ﹤0.01% | 1515 |
|
|
2021
Q4 | – | Sell |
-3,921
| Closed | -$51K | – | 2375 |
|
|
2021
Q3 | $51K | Buy |
+3,921
| New | +$51K | ﹤0.01% | 1678 |
|
|
2021
Q1 | – | Sell |
-77,200
| Closed | -$878K | – | 1929 |
|
|
2020
Q4 | $878K | Buy |
77,200
+35,821
| +87% | +$407K | ﹤0.01% | 911 |
|
|
2020
Q3 | $372K | Buy |
+41,379
| New | +$372K | ﹤0.01% | 902 |
|
|
2020
Q2 | – | Sell |
-8,536
| Closed | -$86K | – | 1696 |
|
|
2020
Q1 | $86K | Buy |
8,536
+4,962
| +139% | +$50K | ﹤0.01% | 1029 |
|
|
2019
Q4 | $47K | Buy |
3,574
+2,101
| +143% | +$27.6K | ﹤0.01% | 1072 |
|
|
2019
Q3 | $12K | Buy |
+1,473
| New | +$12K | ﹤0.01% | 1261 |
|